ArticleOphthalmology and therapy2018

A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma.

Francisco Gómez-Aguayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.